Press release
Emerging Euvichol Or Euvichol-Plus Market Driver 2025-2034: Rising Liver Diseases Prevalence To Drive Growth Of The Market
Emerging Euvichol Or Euvichol-Plus Market Driver
Recent years have seen the market size for euvichol or euvichol-plus expanding at a HCAGR of $XX. It is projected to expand from $XX million in 2024 to $XX million in 2025, indicating a compound annual growth rate (CAGR) of $XX%. Historical growth trends can be traced back to the rising demand for generic UDCA, enhanced knowledge among healthcare providers, increased consciousness about NASH and liver health, a surge in the demand for personalized liver health services, and the need for pharmaceutical therapies.
The market size of euvichol or euvichol-plus is predicted to experience $XX growth over the upcoming years, reaching a value of $XX million by 2029 at a compound annual growth rate (CAGR) of $XX%. This growth during the predicted period is likely due to the escalating prevalence of conditions such as chronic kidney disease (CKD), liver fibrosis, obesity, type 2 diabetes, NASH, NAFLD, and non-alcoholic fatty liver disease (NAFLD). Key trends expected during this period involve technological improvements in drug delivery systems, advancements in diagnostic techniques, an emphasis on biopharmaceutical breakthroughs, progress in drug development, and the rising use of telemedicine and digital health platforms.
What Is Stimulating Growth in the Euvichol Or Euvichol-Plus Market?
The amplified occurrence of liver-related disorders is expected to steer the expansion of the euvichol or euvichol-plus market in the near future. Liver disorders are a broad array of medical issues that hinder the liver's capacity to function optimally. The escalating prevalence of liver disorders is primarily attributable to the growth in obesity, which leads to non-alcoholic fatty liver disease, and heightened alcohol consumption, a primary culprit for alcoholic liver disease. Euvichol and Euvichol Plus play a crucial role in treating liver disorders, especially chronic hepatitis B, by enhancing liver cell membrane integrity, lowering inflammation, and supporting liver functionality. For instance, hospital admission rates for liver diseases surged to 155.2 per 100,000 population in the fiscal year ending 2023, from 150.6 per 100,000 in 2022, as reported by GOV.UK, a UK-oriented governmental agency, in April 2024. Consequently, the rising frequency of liver disorders is propelling the growth of the euvichol or euvichol-plus market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20065&type=smp
Which Key Market Leaders Are Driving Euvichol Or Euvichol-Plus Industry Growth?
Major companies operating in the euvichol or euvichol-plus market include Eubiologics Co. Ltd.; Techinvention Lifecare Pvt. Ltd.
What Are the Latest Innovations in the Euvichol Or Euvichol-Plus Market?
One prevailing tendency in the euvichol or euvichol-plus market involves the creation of technologically superior solutions, such as the oral cholera vaccine, to satisfy various key sector requirements. Oral cholera vaccines, which are consumed orally to guard against cholera, an infection leading to intense diarrhea and dehydration, are a case in point. In May 2023, Techinvention Lifecare Pvt. Ltd., a biotech firm based in India, launched the market's first oral cholera vaccine, Euvichol-Plus, packaged in a low-density polyethylene (LDPE) unidose pack. This novel packaging form not only increases usability but also improves safety by lowering the chances of breakage and waste usually related to conventional glass vials. Following the successful completion of a phase III clinical trial and approval by the Central Drugs Standard Control Organization (CDSCO), Euvichol-Plus aims to tackle a crucial public health issue in India, where cholera threatens roughly 400 million individuals. This vaccine is set to enhance distribution during urgent situations and humanitarian crises, contributing to international endeavors to eliminate cholera by 2030.
What Are the Main Segments in the Euvichol Or Euvichol-Plus Market?
The euvichol or euvichol-plus market covered in this report is segmented -
1) By Product Type: Euvichol, Euvichol-Plus
2) By Clinical Indication: Non-Alcoholic Fatty Liver Disease (NAFLD), Liver Dysfunction, Detoxification And Liver Protection
3) By Distribution Channel: Hospitals And Clinics, Pharmacies, Public Health Campaigns
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/euvichol-or-euvichol-plus-global-market-report
Which Geographic Area Leads the Euvichol Or Euvichol-Plus Market?
North America was the largest region in the euvichol or euvichol-plus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the euvichol or euvichol-plus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Euvichol Or Euvichol-Plus Global Market Report?
- Market Size Analysis: Analyze the euvichol or euvichol-plus Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the euvichol or euvichol-plus market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall euvichol or euvichol-plus market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the euvichol or euvichol-plus market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20065
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Euvichol Or Euvichol-Plus Market Driver 2025-2034: Rising Liver Diseases Prevalence To Drive Growth Of The Market here
News-ID: 3872851 • Views: …
More Releases from The Business research company
Leading Companies Reinforce Their Presence in the Blanket Market
The blanket market is steadily gaining traction as consumers increasingly seek comfort and style in their home essentials. With evolving preferences and technological advancements, this sector is set to experience consistent growth. Let's explore the current market value, key players, emerging trends, and the main segments fueling this expansion.
Forecasted Blanket Market Size and Growth Trajectory
The blanket market has seen consistent growth over recent years. From a market size…
Global Trends Review: The Rapid Evolution of the Sporting and Athletic Goods Mar …
The sporting and athletic goods market is experiencing steady growth, driven by evolving consumer preferences and technological advancements. As health and wellness continue to gain importance globally, this market is set for notable expansion in the coming years. Let's explore the current market size, key factors fueling its growth, leading companies, major trends, and segmentation details.
Forecast for Sporting and Athletic Goods Market Size Through 2029
The sporting and athletic…
Train Seat Market Overview, Key Growth Factors, and Insights on Top Players
The train seat industry is experiencing notable growth, driven by advancements in technology and increasing demand for improved passenger comfort. As rail travel evolves, so does the need for innovative, efficient, and adaptable seating solutions that cater to modern requirements. Let's explore the current market status, key players, trends, and segments shaping the future of train seating.
Train Seat Market Size and Growth Expectations
The train seat market has seen…
Leading Companies Solidifying Their Presence in the Spunbond Nonwovens Market
The spunbond nonwovens industry has been experiencing notable growth and shows promising prospects for the coming years. This expanding market is being driven by several innovations and increasing demand across diverse sectors, signaling a robust future.
Projected Growth and Market Size of the Spunbond Nonwovens Market
The spunbond nonwovens market has demonstrated solid expansion recently, with its size expected to rise from $15.57 billion in 2024 to $16.59 billion in…
More Releases for Euvichol
Global Cholera Vaccine Market to Exceed USD 1.02 Billion by 2031, Driven by Outb …
[Geneva, 3 July 2025] - Clearview Market Insights (CVMI) projects that the global cholera vaccine market will grow from USD 430 million in 2024 to USD 1.02 billion by 2031, registering a CAGR of 12.8%. Growth is driven by increasing demand in cholera-endemic regions, expanding WHO stockpile programs, and innovations in vaccine delivery.
"Cholera vaccines are crucial tools in preventing the disease's spread among vulnerable populations worldwide, especially amid increasing…
Global Euvichol Or Euvichol-Plus Market Analysis 2025-2030: Growth Drivers, Chal …
The Euvichol Or Euvichol-Plus Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_
_x000D_
What Is the Euvichol Or Euvichol-Plus Market Size and Projected Growth Rate?_x000D_
In recent times, the market size for euvichol or euvichol-plus has witnessed a (HCAGR) of XX. The market is projected to expand…
In-Depth Analysis of the Euvichol Or Euvichol-Plus Market: Growth Opportunities, …
What market dynamics are playing a key role in accelerating the growth of the euvichol or euvichol-plus market?
The escalating incidence of liver diseases is expected to fuel the expansion of the euvichol or euvichol-plus market in the upcoming years. Liver diseases encompass a variety of health disorders that hinder the liver's normal functionality. The increased incidence of these diseases can largely be attributed to the surge in obesity levels, leading…
Global Cholera Vaccines Market 2024-2032: Top Key Players - Astellas Pharma Inc. …
IMARC Group's report titled "Cholera Vaccines Market Report by Vaccine Type (Whole Cell V. Cholerae O1 with Recombinant B-Subunit, Killed Oral O1 and O139), Product (Dukoral, Shanchol, Vaxchora, Euvichol and Euvichol-Plus, and Others), End User (Hospitals and Clinics, Research and Academic Laboratories, and Others), and Region 2024-2032". The global cholera vaccines market size reached US$ 5.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0…
Cholera Vaccine Market 2023 Size, Share, Industry, Forecast to 2030
The Cholera Vaccine Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Cholera Vaccine market. This report explores all the key factors affecting the growth of the global Cholera Vaccine market, including…
CHOLERA VACCINE MARKET TOP KEY PLAYERS: VALNEVA SE, EMERGENT BIOSOLUTIONS, INC. …
A fresh report titled “Cholera Vaccine Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Cholera Vaccine Market. The competition analysis is also a major part of the report.
The global cholera vaccine market generated $65 million in…
